Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pre-Resection Minimally Invasive Surgical Restaging of Stage III (Mediastinal Node Positive) Non-Small Cell Lung Cancer (NSCLC)

NCT00003566 is registered in ClinicalTrials.gov with Alliance for Clinical Trials in Oncology as lead sponsor.

NCT NCT00003566
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003566 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pre-Resection Minimally Invasive Surgical Restaging of Stage III (Mediastinal Node Positive) Non-Small Cell Lung Cancer (NSCLC)
Lead sponsor
Alliance for Clinical Trials in Oncology
Phase
Not applicable
Overall status
Completed
Start date
September 30, 1998
Completion date
March 31, 2006
Enrollment
75 (actual)
Sites
72

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer